Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: CSR, SRI

Elie Hirschfeld Foundation Dedicates Gift to Weizmann Institute of Science in Israel


NEW YORK, Sept. 14, 2020 /PRNewswire/ -- The Elie Hirschfeld Foundation announces the dedication of $100,000 to the Weizmann Institute of Science in Israel. The donation will support the medical research of scientists working in relation to cellular dynamics, adaptive immune response, molecular regulation, and cellular dynamics. The work currently being done is in relation to COVID-19.

"I am thrilled to be able to support the ongoing work of these physicians, via the Weizmann Institute," said Elie Hirschfeld. "Viral immunology has never been more important than it is today."

Ziv Shulman MD and Rony Dahan MD, and frequent collaborator Sarah Schlesinger MD of the Rockefeller University, are all specialists in viral immunology currently working on matters related to COVID-19. Dr. Shulman's work is on the cellular dynamics and molecular regulation of the adaptive immune response, and Dr. Dahan's work focuses on antibody effector functions in immunology and immunotherapy. Dr. Schlesinger chairs The Rockefeller University Institutional Review Board and the University's Post Doctoral Education Committee. She collaborated for many years until his death with Nobel Laureate Ralph Steinman MD on the subject of dendric cells, which he discovered, to fight infectious diseases, like COVID-19.

About The Elie Hirschfeld Foundation:

According to Elie Hirschfeld, philanthropy is the voluntary promotion for the benefit of humanity. The Foundation's values center on community enhancement and support, with focus in several areas: Education, Healthcare, Jewish causes, New York City and Art.  Recently Elie and his wife Sarah made a major contribution of their art collection focusing on Scenes of New York City to the New York Historical Society. With a personal history of giving that goes back to his years as a student serving as President of Brown University's Hillel chapter, Elie has remained inspired by that organization's commitment to enriching the Jewish people and repairing the world.  Elie believes that giving back to the community, and to humanity, offers both personal and societal enrichment. He created the Elie Hirschfeld Foundation as a means of expanding upon these efforts.

For More Information Please Contact:

Elie Hirschfeld Foundation
645 Madison Avenue
New York, NY 10022
Ph:       212.355.3838
Fax:      212.980.3838 

SOURCE Elie Hirschfeld Foundation


These press releases may also interest you

at 16:05
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the full year ended December 31, 2023, and provided an overview of recent developments....

at 16:05
Bristol Myers Squibb today announced an update following the initial analysis of results from the first of two induction studies in the Phase 3 YELLOWSTONE clinical trial program evaluating Zeposia (ozanimod) in adult patients with moderate to...

at 16:05
Personalis, Inc. , a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time. About Personalis, Inc....

at 16:05
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter and full year ended December...

at 16:05
Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fourth quarter and year-end 2023 financial...

at 16:05
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2023...



News published on and distributed by: